Effect of the C-terminus of murine S100A9 protein on experimental nociception

Peptides

Volumn 27, Issue 11, 2006, Pages 2794-2802

  Dale, Camila Squarzoni ^a   Pagano, Rosana de Lima ^a   Paccola, Carina Cicconi ^a   Pinotti Guirao, Tatiana ^a   Juliano, Maria Aparecida ^b   Juliano, Luiz ^b   Giorgi, Renata ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carrageenan; Hyperalgesia; Inflammation; Nociception; S100A9

Indexed keywords

CARRAGEENAN; HISTIDYLGLUTAMYLLYSYLLEUCYLHISTIDYLGLUTAMYLASPARAGINYLASPARAGINYLPROLYL ARGINYLGLYCYLHISTIDYLGLYCYLHISTIDYLGLYCYLHISTIDYLSERYLHISTIDYLGLYCYLLYSYL GLYCIN E; MORPHINE; PEPTIDE DERIVATIVE; PROTEIN S 100; PROTEIN S 100A9; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HOT PLATE TEST; HYPERALGESIA; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; WRITHING TEST;

ANIMALS; CALGRANULIN B; CARRAGEENAN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; MALE; MICE; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

MURINAE;

EID: 33750070352     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.07.002     Document Type: Article

References (49)

1. Aguiar-Passeti T., Postol E., Sorg C., and Mariano M. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J Leuk Biol 62 (1997) 852-858
2. Brun J.G., Ulvestad E., Fagerhol M.K., and Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol 40 (1994) 675-680
3. Brun J.G., Haland G., Haga H., Fagerhol M.K., and Jonsson R. Effects of calprotectin in avidrine-induced arthritis. APMIS 103 (1995) 233-240
4. Clohessy P.A., and Golden B.E. His-X-X-X-His motif in S100 protein, calprotectin: relation to microbiostatic activity. J Leuk Biol 60 (1996) 74
5. Cunha F.Q., Lorenzetti B.B., Poole S., and Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br J Pharm 104 (1991) 765-767
6. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br J Pharm 107 (1992) 660-664
7. Dale C.S., Gonçalves L.R.C., Juliano L., Juliano M.A., Moura-da-Silva A.M., and Giorgi R. The C-terminus of murine S100A9 protein inhibits hyperalgesia and edema induced by jararhagin. Peptides 25 (2004) 81-89
8. D'Amour F.E., and Smith D.L. A method for determining loss of pain sensation. J Pharm Exp Ther 72 (1941) 9
9. Dray A. Peripheral mediators of pain. In: Dickenson A., and Besson J.M. (Eds). The pharmacolcogy of pain (1997), Springer Edition, Germany 21-41
10. Dray A., and Bevan S. Inflammation and hyperalgesia: highlighting the team effort. TIPS 14 (1993) 287-290
11. Duarte I.D.G., Nakamura M., and Ferreira S.H. Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res 21 (1988) 341-343
12. Ferreira S.H. Prostaglandins aspirin-like drugs analgesia. Nat New Biol 240 (1972) 200-203
13. Ferreira S.H., Monacada S., and Vane J.R. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharm 49 (1973) 86-97
14. Ferreira S.H., and Nakamura III M. Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid-antagonists. Prostaglandins 18 (1979) 201-208
15. Ferreira S.H., Lorenzetti B.B., and Era G.A. Is methylnalorphinium the prototype of an ideal peripheral analgesic?. Eur J Pharm 99 (1984) 23-29
16. Ferreira S.H., Lorenzetti B.B., Bristow A.F., and Poole S. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334 (1988) 698-700
17. Ferreira S.H. A classification of peripheral analgesics based upon their mode of action. In: Sandler M., and Collins G.M. (Eds). Migraine: spectrum of ideas (1990), Oxford University Press 59-72
18. Ferreira S.H., Lorenzetti B.B., and Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharm 110 (1993) 1227-1231
19. Freemont P., Hoog N., and Edgeworth J. Sequence identity. Nature 339 (1989) 516
20. Foell D., Frosch M., Sorg C., and Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 344 (2004) 37-51
21. Giorgi R., Pagano R., Amorim-Dias M.A., Aguiar-Passseti T., Sorg C., and Mariano M. Antinociceptive effect of calcium-binding protein MRP-14 and the role played by neutrophils on the control of inflammatory pain. J Leuk Biol 64 (1998) 214-220
22. Golden B.E., Clohessy P.A., Russel G., and Fagerhol M.K. Calprotectin as a marker of inflammation in cystics fibrosis. Arch Dis Child 74 (1993) 136-139
23. Grosman M.L., Basbaum A.I., and Fields H.L. Afferent and efferent connections of the rat tail flick reflex (a model used to analyse pain control mechanisms). J Comp Neurol 206 (1982) 9-16
24. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
25. 2+ binding proteins of neutrophils and monocytes. J Leuk Biol 53 (1993) 197-204
26. Hessian A.P., Wilkinson L., and Hoog N. The S-100 family protein MRP-14 (S100A9) has homology with the contact domain of high molecular weight kininogen. FEBS Lett 371 (1995) 271-275
27. Hogg N., Allen C., and Edgeworth J. Monoclonal antibody 5.5 reacts with p8.14, a myeloid molecule associated with some vascular endothelium. Eur J Immunol 19 (1989) 1051-1053
28. Jacob J.J.C., and Ramabadran K. Enhancement of a nociceptive reaction by opioid antagonists in mice. Br J Pharm 64 (1978) 91-98
29. Jensen T.S., and Yaksh T.L. Comparison of antinociceptive action of morphine in the periaqueductal gray medial and paramedial medulla in rat. Brain Res 363 (1986) 99-113
30. Koster R., Anderson M., and De Beer E.J. Acetic acid for analgesic screening. Fed Proc 18 (1959) 412
31. Lavich T.R., Cordeiro R.S., Calixto J.B., e Silva P.M., and Martins M.A. Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats. Eur J Pharm 462 (2003) 185-192
32. Levine J.D., and Reichling D.B. Peripheral mechanisms of inflammatory pain. In: Wall P.D., and Melzack R. (Eds). Textbook of pain. 4th ed (1999), Churchill Livingstone Edition, Edinburgh 59-84
33. Loomans H.J., Hahn B.L., Li Q.Q., Phadnis S.H., and Sohnle P.G. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J Infect Dis 177 (1998) 812-814
34. Meller S.T., Cummings C.P., Traub R.J., and Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 60 (1994) 367-374
35. Nacken W., Roth J., Sorg C., and Kerkhoff C. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 60 (2003) 569-580
36. Odink K., Cerletti N., Brunger J., Clerc R.G., Tarcsay L., Zwaldo G., et al. Two calcium-biding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330 (1987) 80-82
37. Pagano R.L., Amorim-Dias M.A., Dale C.S., and Giorgi R. Neutrophils and the protein MRP-14 mediate carrageenan-induced antinociception in mice. Med Inflamm 11 (2002) 203-210
38. Pagano R.L., Sampaio S.C., Juliano L., Juliano M.A., and Giorgi R. The C-terminus of murine S100A9 inhibits spreading and phagocytic activity of adherent peritoneal cells. Inflamm Res 54 (2005) 204-210
39. Raftery M.J., Harrison C.A., Alewood P., Jones A., and Geczy C.L. Isolation of the murine S100 protein MRP-14 (14 kDa migration inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding. Biochem J 316 (1996) 285-293
40. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflammed tissue. Arch Int Pharm 111 (1957) 209-219
41. Ribeiro R.A., Vale M.L., Thomazzi S.M., Paschoalato A.B.P., Poole S., Ferreira S.H., et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid an mice. Eur J Pharm 387 (2000) 111-118
42. Roth J., Vogl T., Sorg C., and Sunderkötter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 24 (2003) 155-158
43. Sopalla C., Leukert N., Sorg C., and Kerkhoff C. Evidence for the involvement of the unique C-tail of S100A9 in the binding of arachidonic acid to the heterocomplex S100A8/A9. Biol Chem 383 (2002) 1895-1905
44. Sorg C. The calcium-binding protein MRP8 and MRP14 in acute and chronic inflammation. Behring Inst Mill 91 (1992) 126-137
45. Steinbakk M., Naess-Andersen C., Lingaas E., Dale I., Brandtzaeg P., and Fagerhol M.K. Antimicrobial actions of calcium binding leukocyte L1 protein, calprotectin. Lancet 336 (1990) 763-765
46. Yui S., Mikami M., and Yamazaki M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J Leuk Biol 58 (1995) 650-658
47. Yui S., Mikasi M., Tsurumaki K., and Yamazaki M. Growth-inhibitory apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J Leuk Biol 61 (1997) 50-57
48. Zimmer D.B., Cornwall E.H., Landar A., and Song W. The S-100 protein family: history, function and expression. Brain Res Bull 37 (1995) 417-429
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110